Archive explorer

Browse & search snapshots

Important note

Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.

For background on coverage and capture methods, see Methods & coverage.

Browse archived sites

Browse all sources →

COVID-19: Mobilizing industry to provide medical supplies Health Canada and other government departments are collaborating with the health product industry to provide medical supplies in response to COVID-19. Initiatives undertaken by Canada will: help identify and fill product…

Applications for medical devices under the Interim Order for use in relation to COVID-19: Guidance document On February 22, 2023, Health Canada introduced the Regulations Amending the Medical Devices Regulations (Interim Order No. 3 Respecting the Importation and Sale of Medical…

Health product highlights 2021: Helping you maintain and improve your health Overview Drugs for human use Medical devices Lower-risk health products Drugs for veterinary use Annexes of products approved in 2021 Download in PDF format (10.7 MB, 84 pages) Organization: Health…

Health product advertising incidents: Proactive monitoring – COVID-19 Overview How to report a complaint Proactive monitoring – COVID-19 Proactive monitoring – Natural health products The World Health Organization (WHO) declared the outbreak of the novel coronavirus (COVID-19) a…

Notice: Regulations amending certain regulations concerning drugs and medical devices (shortages) Date published: September 1 st , 2021 The Regulations Amending Certain Regulations Concerning Drugs and Medical Devices (Shortages) were made on August 11 th , 2021. They amend the…

Notice to stakeholders: Final guidance document for industry and practitioners on the Special Access Program (SAP) for drugs October 14, 2020 The Therapeutic Products Directorate (TPD) has published the final guidance document for industry and practitioners on the Special Access…

Drug and vaccine authorizations for COVID-19: List of applications received Overview List of applications received List of authorized products This page has been archived. Refer to the Lists of Drug and Health Product Submissions Under Review for more information. Date published:…

Guidance on applications for COVID-19 medical device clinical trials under the Regulations: Overview Overview Application processes Post-authorization requirements Incidents, record keeping and recalls General requirements Attestation form Published: March 2, 2022 This guidance…

Guidance on applications for COVID-19 drug clinical trials under the Regulations: Overview Overview Application process Additional requirements Post-authorization requirements General requirements Who to contact This guidance document supports the Clinical Trials for Medical…

ARCHIVED Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Notice to Reader: We have replaced the Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19. See the regulations notice about…

Page 2288 of 3977Showing 22871-22880 of 39762

Early release: coverage and features are still expanding.